Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...

Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global inhaled therapy in respiratory disease market size is calculated at USD 11.98 billion in 2025 and is expected to reach around USD 16.22 billion by ...

DUBLIN--(BUSINESS WIRE)--The "Respiratory Inhalers Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven ...

CHARLOTTE, N.C., Feb. 22, 2022 /PRNewswire/ -- Honeywell (Nasdaq: HON) today announced a commercial partnership with AstraZeneca (LON: AZN) to develop and bring to market next-generation respiratory ...

North Carolina-based Pneuma Respiratory has announced a fully digital soft mist inhaler device. The inhaler can deliver several different types of medicines directly to the lungs, and by syncing with ...

Respiratory disease patients with arthritis could struggle to manage their conditions because their inhalers are too fiddly for them to use, University of Bath research has found. Medical ...

(RTTNews) - British drug major AstraZeneca is joining with U.S. Technology major Honeywell to develop next-generation respiratory inhalers that use near-zero global warming potential or GWP ...

NEW YORK, July 31, 2024 /PRNewswire/ -- The global smart inhaler technology market size is estimated to grow by USD 46.37 million from 2023-2027, according to Technavio. The market is estimated to ...

Key drivers include developments in smart and sustainable designs. The respiratory inhaler devices market is expected to ...

CHICAGO, Aug. 27, 2020 /PRNewswire/ -- The global respiratory inhalers market is expected to grow at a CAGR of over 9% during the period 2019−2025. Key Highlights Offered in the Report: The US ...